title: The role of oxidative stress in anticancer activity of sesquiterpene lactones.
abstract: Sesquiterpene lactones (SLs) are plant-derived compounds that are abundant in plants of the Asteraceae family and posses a broad spectrum of biological activities, ranging from anti-inflammatory, phytotoxic, antibacterial, and antifungal to cytotoxic/anticancer. In recent years, anticancer properties of these compounds and molecular mechanisms of their action have been studied extensively on numerous cell lines and also on experimental animals. SLs have been shown to disrupt cellular redox balance and induce oxidative stress in cancer cells. Oxidative stress is associated with increased production of reactive oxygen species (ROS) which in turn can promote many aspects of cancer development and progression. On the other hand, ROS, which initiate apoptosis via the mitochondrial-dependent pathway, can also be used to kill cancer cells, if they can be generated in cancer. One of the most important regulators of the redox equilibrium in the cells is reduced glutathione (GSH). In cancer cells, GSH levels are higher than in normal cells. Therefore, SL can induce apoptosis of cancer cells by decreasing intracellular GSH levels. The use of SL which can affect intracellular redox signaling pathways can be considered an interesting approach for cancer treatment. In this review, we give a brief description of the mechanisms and pathways involved in oxidative stress-induced anticancer activity of SL.
authors: Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
authors: Katarzyna
authors: K
authors: Gach
authors: Angelika
authors: A
authors: Długosz
authors: Anna
authors: A
authors: Janecka
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D045744:Cell Line, Tumor; D006801:Humans; D007783:Lactones / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress / Q000187:drug effects*; D010946:Plants, Medicinal / Q000737:chemistry; D017382:Reactive Oxygen Species / Q000378:metabolism; D012717:Sesquiterpenes / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D007783:Lactones; D017382:Reactive Oxygen Species; D012717:Sesquiterpenes
references: Inflammation. 2012 Apr;35(2):560-5
references: 21603970
references: J Biol Chem. 2002 Oct 11;277(41):38954-64
references: 12151389
references: Environ Health Perspect. 1994 Dec;102 Suppl 10:5-12
references: 7705305
references: Science. 1977 Apr 29;196(4289):533-6
references: 191909
references: Free Radic Res. 2008 Aug;42(8):689-706
references: 18671159
references: Cancer Res. 2007 Apr 1;67(7):3371-8
references: 17409447
references: Biochem Biophys Res Commun. 1999 Aug 27;262(2):375-80
references: 10462483
references: Cancer Res. 1991 Feb 1;51(3):794-8
references: 1846317
references: Cell Death Dis. 2013 Oct 31;4:e891
references: 24176849
references: Metabolism. 2000 Feb;49(2 Suppl 1):3-8
references: 10693912
references: Chem Biol. 2007 Jul;14(7):813-23
references: 17656318
references: Curr Cancer Drug Targets. 2014;14 (1):59-69
references: 24200081
references: Endocr Relat Cancer. 2006 Jun;13(2):607-16
references: 16728586
references: Anticancer Drugs. 2012 Oct;23(9):883-96
references: 22797176
references: Blood. 2001 Oct 15;98 (8):2301-7
references: 11588023
references: Int J Cancer. 2011 May 15;128(10 ):2481-94
references: 20669221
references: Mini Rev Med Chem. 2014;14(3):222-8
references: 24552263
references: J Pharmacol Exp Ther. 2009 May;329(2):505-14
references: 19201992
references: Curr Drug Targets. 2011 Oct;12(11):1560-73
references: 21561425
references: J Med Chem. 2012 Oct 25;55(20):8757-69
references: 22985027
references: Cell Death Differ. 2004 Jul;11 Suppl 1:S73-85
references: 15105835
references: J Nat Prod. 1997 Mar;60(3):252-7
references: 9090867
references: Antioxid Redox Signal. 2010 Aug 15;13(4):449-65
references: 20017602
references: Blood. 2007 Dec 15;110(13):4427-35
references: 17804695
references: Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12831-6
references: 16908843
references: J Med Chem. 1972 Jun;15(6):609-11
references: 5030926
references: Leukemia. 2006 Jun;20(6):1073-9
references: 16628188
references: Bioorg Med Chem. 2008 Jan 15;16(2):721-31
references: 17980607
references: Mol Cancer Ther. 2007 Sep;6(9):2544-53
references: 17876051
references: Cancer Lett. 2007 Aug 28;254(1):119-27
references: 17470383
references: Blood. 2013 Feb 21;121(8):1384-93
references: 23264600
references: Free Radic Biol Med. 2010 Mar 15;48(6):749-62
references: 20045723
references: Biol Pharm Bull. 2001 Mar;24(3):303-6
references: 11256490
references: Bioorg Med Chem. 2007 Apr 15;15(8):2927-34
references: 17336532
references: Nat Prod Rep. 1995 Jun;12(3):271-6
references: 7792073
references: Curr Opin Drug Discov Devel. 2009 Mar;12(2):240-5
references: 19333869
references: Cancer Lett. 2004 May 28;208(2):143-53
references: 15142672
references: Mol Immunol. 2009 Sep;46(15):2892-901
references: 19656571
references: Blood. 2005 Jun 1;105(11):4163-9
references: 15687234
references: J Exp Clin Cancer Res. 2010 Aug 10;29:108
references: 20698986
references: Biol Pharm Bull. 2013;36(7):1118-25
references: 23657090
references: Cytokine. 2000 Mar;12 (3):239-45
references: 10704251
references: IUBMB Life. 2012 Sep;64(9):783-94
references: 22837216
references: Clin Cancer Res. 2003 Jan;9(1):346-54
references: 12538487
references: Indian J Exp Biol. 2002 Nov;40(11):1233-9
references: 13677624
references: Int J Mol Med. 2011 Dec;28(6):1033-42
references: 21805026
references: Molecules. 2013 Jan 24;18(2):1418-33
references: 23348995
references: Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
references: 20840865
references: Curr Med Chem Anticancer Agents. 2005 May;5(3):239-49
references: 15992352
references: FEBS Lett. 1995 Jan 16;358(1):1-3
references: 7821417
references: Eur J Med Chem. 2013 May;63:313-20
references: 23501116
references: Drug Discov Today. 2012 Jun;17(11-12):561-72
references: 22309965
references: Bioorg Med Chem. 1999 Nov;7(11):2343-52
references: 10632044
references: Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302
references: 19249331
references: Apoptosis. 2006 Dec;11(12):2225-35
references: 17051330
references: J Nat Med. 2013 Jul;67(3):468-79
references: 22976170
references: Anticancer Res. 2009 Apr;29(4):1449-57
references: 19414401
references: Oncogene. 2004 Sep 23;23(44):7330-44
references: 15286701
references: Bioorg Med Chem Lett. 2008 Jul 15;18(14):3870-3
references: 18590961
references: Prostate. 2010 Jul 1;70(10):1074-86
references: 20209491
references: Mini Rev Med Chem. 2007 Feb;7(2):131-9
references: 17305587
references: Bioorg Med Chem Lett. 2009 Aug 1;19(15):4346-9
references: 19505822
references: Br J Cancer. 1989 Jan;59(1):68-75
references: 2757925
references: Mol Med Rep. 2013 Oct;8(4):967-72
references: 23970102
references: Biol Pharm Bull. 2009 Oct;32(10):1803-8
references: 19801848
references: Nat Immunol. 2002 Mar;3(3):221-7
references: 11875461
references: Int J Mol Sci. 2013 Jun 19;14(6):12780-805
references: 23783276
references: Biomed Res Int. 2013;2013:719858
references: 23533997
references: Bioorg Med Chem. 2001 Aug;9(8):2189-94
references: 11504656
references: PLoS One. 2009 Dec 02;4(12):e8115
references: 19956548
references: Clin Cancer Res. 2008 Mar 15;14(6):1814-22
references: 18347184
references: Clin Cancer Res. 2013 Aug 15;19(16):4309-14
references: 23719265
references: Postepy Hig Med Dosw (Online). 2010 Mar 16;64:100-14
references: 20354259
references: Int J Biochem Cell Biol. 2007;39(1):44-84
references: 16978905
references: Cancer Cell. 2006 Sep;10(3):175-6
references: 16959608